{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:14:43Z","timestamp":1793128483346,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270278"],"award-info":[{"award-number":["82270278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-025-10114-7","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:51:43Z","timestamp":1764226303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The novel sphingosine-1-phosphate receptor modulator KRP-203 prevents myocardial ischemia\u2013reperfusion injury by preserving mitochondrial function through activation of the RISK and SAFE signaling pathways"],"prefix":"10.1007","volume":"41","author":[{"given":"Nan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haomeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"10114_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00645","volume":"8","author":"N Ahmed","year":"2017","unstructured":"Ahmed N, Linardi D, Muhammad N, et al. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) attenuates myocardial fibrosis in post-heterotopic heart transplantation. Front Pharmacol. 2017;8:645.","journal-title":"Front Pharmacol"},{"key":"10114_CR2","doi-asserted-by":"crossref","unstructured":"Ahmed N, Mehmood A, Linardi D, et al. Cardioprotective effects of sphingosine-1-phosphate receptor immunomodulator FTY720 in a clinically relevant model of cardioplegic arrest and cardiopulmonary bypass. Front Pharmacol. 2019;10802.","DOI":"10.3389\/fphar.2019.00802"},{"key":"10114_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1148932","volume":"14","author":"M Behara","year":"2023","unstructured":"Behara M, Goudy S. FTY720 in immuno-regenerative and wound healing technologies for muscle, epithelial and bone regeneration. Front Physiol. 2023;14:1148932. https:\/\/doi.org\/10.3389\/fphys.2023.1148932.","journal-title":"Front Physiol"},{"key":"10114_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells11132058","author":"\u00c1G Bravo","year":"2022","unstructured":"Bravo \u00c1G, Cede\u00f1o RR, Casadevall PM, et al. Sphingosine-1-phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11132058.","journal-title":"Cells"},{"issue":"7","key":"10114_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1600-6143.2004.00476.x","volume":"4","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Cyster JG, Hla T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant. 2004;4(7):1019\u201325.","journal-title":"Am J Transplant"},{"issue":"1","key":"10114_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010159","volume":"13","author":"M Buske","year":"2023","unstructured":"Buske M, Desch S, Heusch G, et al. Reperfusion injury: how can we reduce it by pre-, per-, and postconditioning. J Clin Med. 2023;13(1):159.","journal-title":"J Clin Med"},{"issue":"1","key":"10114_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.31083\/j.rcm.2020.01.10","volume":"21","author":"E Chen","year":"2020","unstructured":"Chen E, Cai W, Hu D, et al. Effect of remote ischemic preconditioning in patients with STEMI during primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Rev Cardiovasc Med. 2020;21(1):103\u201312.","journal-title":"Rev Cardiovasc Med"},{"key":"10114_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113341","volume":"153","author":"H Chen","year":"2022","unstructured":"Chen H, Wang J, Zhang C, et al. Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases. Biomed Pharmacother. 2022;153:113341.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10114_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00395-021-00898-0","volume":"116","author":"S Comit\u00e0","year":"2021","unstructured":"Comit\u00e0 S, Femmino S, Thairi C, et al. Regulation of STAT3 and its role in cardioprotection by conditioning: focus on non-genomic roles targeting mitochondrial function. Basic Res Cardiol. 2021;116(1):56.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"10114_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.biocel.2005.09.017","volume":"38","author":"SM Davidson","year":"2006","unstructured":"Davidson SM, Hausenloy D, Duchen MR, et al. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol. 2006;38(3):414\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"10114_CR12","first-page":"2451","volume":"43","author":"L Duan","year":"2019","unstructured":"Duan L, Liang C, Li X, et al. Lycopene restores the effect of ischemic postconditioning on myocardial ischemia-reperfusion injury in hypercholesterolemic rats. Int J Mol Med. 2019;43(6):2451\u201361.","journal-title":"Int J Mol Med"},{"issue":"6","key":"10114_CR13","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/01.tp.0000232687.78242.cd","volume":"82","author":"J Fujishiro","year":"2006","unstructured":"Fujishiro J, Kudou S, Iwai S, et al. Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation. Transplantation. 2006;82(6):804\u201312.","journal-title":"Transplantation"},{"issue":"11","key":"10114_CR14","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/1440-1681.12465","volume":"42","author":"D Goltz","year":"2015","unstructured":"Goltz D, Huss S, Ramadori E, et al. Immunomodulation by splenectomy or by FTY720 protects the heart against ischemia reperfusion injury. Clin Exp Pharmacol Physiol. 2015;42(11):1168\u201377.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"10114_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2174\/0115680266273421231222061620","volume":"24","author":"M Han","year":"2024","unstructured":"Han M, Liu X, Hailati S, et al. Pharmacological effects of FTY720 and its derivatives. Curr Top Med Chem. 2024;24(3):192\u2013200.","journal-title":"Curr Top Med Chem"},{"key":"10114_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2025.102046","volume":"84","author":"Y He","year":"2025","unstructured":"He Y, Ren S, Liu C, et al. Targeting mitochondrial quality control for myocardial ischemia-reperfusion injury. Mitochondrion. 2025;84:102046.","journal-title":"Mitochondrion"},{"issue":"4","key":"10114_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","volume":"116","author":"G Heusch","year":"2015","unstructured":"Heusch G. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res. 2015;116(4):674\u201399.","journal-title":"Circ Res"},{"issue":"13\u201314","key":"10114_CR18","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.intimp.2006.07.030","volume":"6","author":"M Hofmann","year":"2006","unstructured":"Hofmann M, Brinkmann V, Zerwes H-G. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs. Int Immunopharmacol. 2006;6(13\u201314):1902\u201310.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10114_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/cvr\/cvp137","volume":"83","author":"U Hofmann","year":"2009","unstructured":"Hofmann U, Burkard N, Vogt C, et al. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion. Cardiovasc Res. 2009;83(2):285\u201393.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10114_CR20","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/j.1476-5381.2010.00767.x","volume":"160","author":"U Hofmann","year":"2010","unstructured":"Hofmann U, Hu K, Walter F, et al. Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion. Br J Pharmacol. 2010;160(5):1243\u201351.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10114_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/1756285616628766","volume":"9","author":"BO Khatri","year":"2016","unstructured":"Khatri BO. Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence. Ther Adv Neurol Disord. 2016;9(2):130\u201347.","journal-title":"Ther Adv Neurol Disord"},{"issue":"7","key":"10114_CR22","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/TP.0b013e3182842396","volume":"95","author":"M Khattar","year":"2013","unstructured":"Khattar M, Deng R, Kahan BD, et al. Novel sphingosine-1-phosphate receptor modulator KRP203 combined with locally delivered regulatory T cells induces permanent acceptance of pancreatic islet allografts. Transplantation. 2013;95(7):919\u201327.","journal-title":"Transplantation"},{"key":"10114_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.650368","volume":"8","author":"J Li","year":"2021","unstructured":"Li J, Zhao C, Zhu Q, et al. Sweroside protects against myocardial ischemia-reperfusion injury by inhibiting oxidative stress and pyroptosis partially via modulation of the Keap1\/Nrf2 axis. Front Cardiovasc Med. 2021;8:650368.","journal-title":"Front Cardiovasc Med"},{"key":"10114_CR24","doi-asserted-by":"crossref","unstructured":"Li X, Jia P, Huang Z, et al. Lycopene protects against myocardial ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Drug Des Devel Ther. 2019;132331\u201342.","DOI":"10.2147\/DDDT.S194753"},{"issue":"1","key":"10114_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s13046-019-1369-7","volume":"38","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zhi Y, Song H, et al. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway. J Exp Clin Cancer Res. 2019;38(1):369.","journal-title":"J Exp Clin Cancer Res"},{"key":"10114_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2023.104565","volume":"149","author":"Y Liu","year":"2023","unstructured":"Liu Y, Li L, Wang Z, et al. Myocardial ischemia-reperfusion injury; molecular mechanisms and prevention. Microvasc Res. 2023;149:104565.","journal-title":"Microvasc Res"},{"key":"10114_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117508","volume":"290","author":"J Liu","year":"2025","unstructured":"Liu J, Zhang L, Liu L, Wu T, et al. The potential capacities of FTY720: novel therapeutic functions, targets, and mechanisms against diseases. Eur J Med Chem. 2025;290:117508.","journal-title":"Eur J Med Chem"},{"key":"10114_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.amjcard.2021.11.014","volume":"166","author":"JM Madsen","year":"2022","unstructured":"Madsen JM, Glinge C, Jabbari R, et al. Comparison of effect of ischemic postconditioning on cardiovascular mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention with versus without thrombectomy. Am J Cardiol. 2022;166:18\u201324.","journal-title":"Am J Cardiol"},{"issue":"5566","key":"10114_CR29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1126\/science.1070238","volume":"296","author":"S Mandala","year":"2002","unstructured":"Mandala S, Hajdu R, Bergstrom J, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 2002;296(5566):346\u20139.","journal-title":"Science"},{"key":"10114_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087374","author":"JP Mu\u00f1oz","year":"2023","unstructured":"Mu\u00f1oz JP, S\u00e0nchez-Fern\u00e0ndez-de-Landa P, Diarte-A\u00f1azco EMG, et al. FTY720-P, a biased S1PR ligand, increases mitochondrial function through STAT3 activation in cardiac cells. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24087374.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10114_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12933-024-02204-3","volume":"23","author":"X Ni","year":"2024","unstructured":"Ni X, Duan L, Bao Y, et al. Circ_005077 accelerates myocardial lipotoxicity induced by high-fat diet via CyPA\/p47PHOX mediated ferroptosis. Cardiovasc Diabetol. 2024;23(1):129.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10114_CR32","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bbrc.2007.07.061","volume":"361","author":"R Ogawa","year":"2007","unstructured":"Ogawa R, Takahashi M, Hirose S-I, et al. A novel sphingosine-1-phosphate receptor agonist KRP-203 attenuates rat autoimmune myocarditis. Biochem Biophys Res Commun. 2007;361(3):621\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10114_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2025.e00549","volume":"22","author":"E Ong","year":"2025","unstructured":"Ong E, Clottes P, Leon C, et al. Mitochondria dysfunction, a potential cytoprotection target against ischemia-reperfusion injury in a mouse stroke model. Neurotherapeutics. 2025;22(2):e00549.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10114_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10741-023-10377-4","volume":"29","author":"P Pastena","year":"2024","unstructured":"Pastena P, Frye JT, Ho C, et al. Ischemic cardiomyopathy: epidemiology, pathophysiology, outcomes, and therapeutic options. Heart Fail Rev. 2024;29(1):287\u201399.","journal-title":"Heart Fail Rev"},{"issue":"21","key":"10114_CR36","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/1873-3468.14973","volume":"598","author":"F Phan","year":"2024","unstructured":"Phan F, Bourron O, Foufelle F, et al. Sphingosine-1-phosphate signalling in the heart: exploring emerging perspectives in cardiopathology. FEBS Lett. 2024;598(21):2641\u201355.","journal-title":"FEBS Lett"},{"key":"10114_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.158127","author":"F Pot\u00ec","year":"2024","unstructured":"Pot\u00ec F, Scalera E, Feuerborn R, et al. Sphingosine 1-phosphate receptor 1signaling in macrophages reduces atherosclerosis in LDL receptor\u2013deficient mice. JCI Insight. 2024. https:\/\/doi.org\/10.1172\/jci.insight.158127.","journal-title":"JCI Insight"},{"key":"10114_CR38","doi-asserted-by":"crossref","unstructured":"Poulsen R R, McClaskey C M, Rivkees S A, et al. The Sphingosine-1-phospate receptor 1 mediates S1P action during cardiac development. BMC Dev Biol. 2011;1137.","DOI":"10.1186\/1471-213X-11-37"},{"issue":"4","key":"10114_CR39","doi-asserted-by":"publisher","first-page":"312","DOI":"10.21037\/atm-20-4414","volume":"9","author":"B Qi","year":"2021","unstructured":"Qi B, Zhang X, Yu H, et al. Brazilin prevents against myocardial ischemia-reperfusion injury through the modulation of Nrf2 via the PKC signaling pathway. Ann Transl Med. 2021;9(4):312.","journal-title":"Ann Transl Med"},{"issue":"2","key":"10114_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/1440-1681.12516","volume":"43","author":"A Rana","year":"2016","unstructured":"Rana A, Sharma S. Mechanism of sphingosine-1-phosphate induced cardioprotection against I\/R injury in diabetic rat heart: possible involvement of glycogen synthase kinase 3\u03b2 and mitochondrial permeability transition pore. Clin Exp Pharmacol Physiol. 2016;43(2):166\u201373.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10114_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2020.106436","volume":"149","author":"Z Raza","year":"2020","unstructured":"Raza Z, Saleem U, Naureen Z. Sphingosine 1-phosphate signaling in ischemia and reperfusion injury. Prostaglandins Other Lipid Mediat. 2020;149:106436.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"1","key":"10114_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11481-017-9727-8","volume":"12","author":"C Ritter","year":"2017","unstructured":"Ritter C, Sva\u010dina MKR, Bobylev I, et al. Impact of age and polytherapy on Fingolimod induced bradycardia: a preclinical study. J Neuroimmune Pharmacol. 2017;12(1):204\u20139.","journal-title":"J Neuroimmune Pharmacol"},{"key":"10114_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052519","author":"S Roth","year":"2021","unstructured":"Roth S, Torregroza C, Feige K, et al. Pharmacological conditioning of the heart: an update on experimental developments and clinical implications. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22052519.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10114_CR44","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/SHK.0000000000001618","volume":"55","author":"M Saber","year":"2021","unstructured":"Saber M, Rice AD, Christie I, et al. Remote ischemic conditioning reduced acute lung injury after traumatic brain injury in the mouse. Shock. 2021;55(2):256\u201367.","journal-title":"Shock"},{"issue":"10","key":"10114_CR45","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1161\/CIRCULATIONAHA.115.012427","volume":"133","author":"CG Santos-Gallego","year":"2016","unstructured":"Santos-Gallego CG, Vahl TP, Goliasch G, et al. Sphingosine-1-phosphate receptor agonist Fingolimod increases myocardial salvage and decreases adverse postinfarction left ventricular remodeling in a porcine model of ischemia\/reperfusion. Circulation. 2016;133(10):954\u201366.","journal-title":"Circulation"},{"key":"10114_CR46","doi-asserted-by":"crossref","unstructured":"Sasset L, Di Lorenzo A. Sphingolipid metabolism and signaling in endothelial cell functions. Adv Exp Med Biol. 2022;1372.","DOI":"10.1007\/978-981-19-0394-6_8"},{"key":"10114_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.892097","volume":"13","author":"JV Selkirk","year":"2022","unstructured":"Selkirk JV, Bortolato A, Yan YG, et al. Competitive binding of Ozanimod and other sphingosine 1-phosphate receptor modulators at receptor subtypes 1 and 5. Front Pharmacol. 2022;13:892097.","journal-title":"Front Pharmacol"},{"issue":"2","key":"10114_CR48","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1161\/01.CIR.0000152101.41037.AB","volume":"111","author":"H Shimizu","year":"2005","unstructured":"Shimizu H, Takahashi M, Kaneko T, et al. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Circulation. 2005;111(2):222\u20139.","journal-title":"Circulation"},{"issue":"3","key":"10114_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10557-012-6376-2","volume":"26","author":"SJ Somers","year":"2012","unstructured":"Somers SJ, Frias M, Lacerda L, et al. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. Cardiovasc Drugs Ther. 2012;26(3):227\u201337.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"10114_CR50","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1124\/jpet.106.119172","volume":"324","author":"J Song","year":"2008","unstructured":"Song J, Matsuda C, Kai Y, et al. A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice. J Pharmacol Exp Ther. 2008;324(1):276\u201383.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10114_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361.","journal-title":"J Comput Chem"},{"issue":"10","key":"10114_CR52","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, et al. Gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput. 2021;17(10):6281\u201391.","journal-title":"J Chem Theory Comput"},{"issue":"26","key":"10114_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302123","volume":"10","author":"Z Wang","year":"2023","unstructured":"Wang Z, Yang N, Hou Y, et al. L-arginine-loaded gold nanocages ameliorate myocardial ischemia\/reperfusion injury by promoting nitric oxide production and maintaining mitochondrial function. Adv Sci. 2023;10(26):e2302123.","journal-title":"Adv Sci"},{"issue":"16","key":"10114_CR54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2117716119","volume":"119","author":"L Yu","year":"2022","unstructured":"Yu L, He L, Gan B, et al. Structural insights into sphingosine-1-phosphate receptor activation. Proc Natl Acad Sci U S A. 2022;119(16):e2117716119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10114_CR55","doi-asserted-by":"publisher","first-page":"H3150","DOI":"10.1152\/ajpheart.00587.2006","volume":"293","author":"J Zhang","year":"2007","unstructured":"Zhang J, Honbo N, Goetzl EJ, et al. Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am J Physiol Heart Circ Physiol. 2007;293(5):H3150\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"22","key":"10114_CR56","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/eurheartj\/ehae031","volume":"45","author":"FH Zuccolotto Dos Reis","year":"2024","unstructured":"Zuccolotto Dos Reis FH. Mitochondria and the heart. Eur Heart J. 2024;45(22):1963\u20134.","journal-title":"Eur Heart J"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10114-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-025-10114-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10114-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T08:07:09Z","timestamp":1764230829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-025-10114-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10114"],"URL":"https:\/\/doi.org\/10.1007\/s10565-025-10114-7","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use and operation of animals were approved by the Laboratory Animal Ethics Committee of China Medical University (KT20240318).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}